← Russell 3000 cross-section

ARDT Ardent Health, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-10, not restated
Healthcare

Scale

Market cap
$1.6bn
Revenue TTM
$6.4bn
Net income TTM
$78m
Free cash flow
Composite score
Sector rank
#1767

Valuation

P / E
20.3
EV / EBITDA
EV / sales
0.3
FCF yield
Earnings yield vs 10-yr
0.20pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
1.2%
EBITDA margin
ROE
5.8%
ROIC
Revenue growth

Insider activity, last 90 days

Net open-market
$0.19m
Buyers
2
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Significant tax provisions of the OBBBA that will impact us include (i) the return to the EBITDA formula used to calculate the business interest expense limitation under Internal Revenue Code ("IRC") Section 163(j) and (ii) the allowance of 100% bonus depreciation for qualifying property placed in service after January 19, 2025. Third party providers of hospital-based physicians, including those with whom we contract, have experienced significant disruption in the form of regulatory changes, including those stemming from enactment of the No Surprises Act, challenging labor market conditions resulting from a shortage of physicians and inflationary wage-related pressures, as well as increased …Ardent Health, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-10

Read the full passage →